Accrol Group Holdings plc, the UK's leading independent tissue converter, has announced its audited final results for the year ended 30 April 2023. The company reported strong growth in both revenue and profit, driven by increasing market share and volumes. Group volumes increased by 7.7% compared to an overall flat tissue market, and market share increased by 200 basis points to 21.5%. Gross margins in the second half of the year improved significantly, and water industry-approved flushable wet wipe sales grew by 169% since the acquisition of the Group's first wet wipes business in 2021. The Group's subscription model, plastic-free, Oceans brand also saw strong revenue growth of 45% year on year. The company's first licensing partnership has progressed well, with the product now stocked in three major UK retailers and further license agreements planned. Accrol is confident of achieving further volume and profit growth in FY24, as it continues to build on its market-leading position. The company's focus on increasing volumes, business mix, and efficiency has already delivered an improvement in margins back to pre-pandemic levels in the first few months of the new financial year. Accrol now expects FY24 EBITDA to be ahead of the Board's prior expectations.